Insights

Gathering insights about MyoKardia…

Similar companies to MyoKardia

MyoKardia Tech Stack

MyoKardia uses 8 technology products and services including Segment, PostgreSQL, Gartner, and more. Explore MyoKardia's tech stack below.

Segment
Customer Data Platforms
PostgreSQL
Database
Gartner
Governance, Risk And Compliance
React
Javascript Frameworks
Combin
Social Media Marketing Software
Adobe Creative Suite
Visualisation Software
Webex
Web Conferencing
Adobe Connect
Web Conferencing

Media & News

MyoKardia's Email Address Formats

MyoKardia uses at least 2 format(s):

MyoKardia Email Formats	Example	Percentage
FLast@myokardia.com	JDoe@myokardia.com	98%
FiLast@myokardia.com	JoDoe@myokardia.com	1%
FMiddleLast@myokardia.com	JMichaelDoe@myokardia.com	1%
First.Last@bms.com	John.Doe@bms.com	94%
LastF@bms.com	DoeJ@bms.com	3%
Last.First@bms.com	Doe.John@bms.com	2%
First.Middle@bms.com	John.Michael@bms.com	1%

Frequently Asked Questions

Where is MyoKardia's headquarters located?

MyoKardia's main headquarters is located at 1000 Sierra Point Parkway Brisbane, California 94005 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is MyoKardia's phone number?

You can contact MyoKardia's main corporate office by phone at

+1-650-741-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MyoKardia's stock symbol?

MyoKardia is a publicly traded company; the company's stock symbol is MYOK.

What is MyoKardia's official website and social media links?

MyoKardia's official website is bms.com and has social profiles on LinkedIn.

How much revenue does MyoKardia generate?

As of July 2024, MyoKardia's annual revenue reached $75M.

What is MyoKardia's SIC code NAICS code?

MyoKardia's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MyoKardia have currently?

As of July 2024, MyoKardia has approximately 201 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Vice President Of Cardiovascular And Fibrosis Discovery Biology: L. C.Vice President - Market Access: M. M.Owner: A. W.. Explore MyoKardia's employee directory with LeadIQ.

What industry does MyoKardia belong to?

MyoKardia operates in the Biotechnology Research industry.

What technology does MyoKardia use?

MyoKardia's tech stack includes SegmentPostgreSQLGartnerReactCombinAdobe Creative SuiteWebexAdobe Connect.

What is MyoKardia's email format?

MyoKardia's email format typically follows the pattern of . Find more MyoKardia email formats with LeadIQ.

When was MyoKardia founded?

MyoKardia was founded in 2012.

MyoKardia

Biotechnology ResearchCalifornia, United States201-500 Employees

We officially combined with Bristol Myers Squibb to further strengthen our scientific capabilities and treatments for cardiovascular patients. Visit www.bms.com to learn more about our work to produce the next generation of medicines for patients with serious cardiovascular disease. 

For more information on the acquisition, see our press release at: https://one.bms.com/40FsT7W

Company Overview

Headquarters: 1000 Sierra Point Parkway Brisbane, California 94005 US
Phone number: ✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-650-741-****
Website: bms.com
SIC Code: 2834 - Pharmaceutical Preparations
Stock Symbol: MYOK
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2012
Employees: 201-500

Media & News

Funding & Financials

$50M$100M
MyoKardia's revenue is in the range of $50M$100M

Funding & Financials

$50M$100M
MyoKardia's revenue is in the range of $50M$100M

Company Leadership

L. C.
Vice President Of Cardiovascular And Fibrosis Discovery Biology
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. M.
Vice President - Market Access
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. W.
Owner
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
I. B.
Senior Vice President Human Resources
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. L.
Senior Vice President, Nonclinical And Pharmaceutical Development
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

R. K.
Vice President, Portfolio Strategy And Alliance Management
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. P.
Associate Director, Rml Leadership
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. W.
Associate Director, Clinical Site Budgets & Contracts
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. S.
Sr. Director, Clinical Process, Standards And Training
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. P.
Associate Director Project Management
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for MyoKardia and Millions of Other Companies
Sign up for full access to MyoKardia information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to MyoKardia

Solid Biosciences

Sarepta Therapeutics

Akcea Therapeutics

MyoKardia Tech Stack

Media & News

Bristol-Myers Squibb Co is developing ex vivo T-cell therapies using Prime's gene-editing reagents based on PASSIGE technology.

Bristol-Myers Squibb Co receives award Financing & Liquidity Award.

Bristol-Myers Squibb Co had issues with suit on Oct 4th '24.

Bristol-Myers Squibb Co signs new client Opdivo.

Bristol-Myers Squibb Co launches Cobenfy.

Harler left Bristol-Myers Squibb Co as president, autoimmunity and inflammation on Jan 1st '21.

University of Texas at San Antonio partners with Bristol-Myers Squibb Co.

MyoKardia's Email Address Formats

Frequently Asked Questions

Where is MyoKardia's headquarters located?

What is MyoKardia's phone number?

What is MyoKardia's stock symbol?

What is MyoKardia's official website and social media links?

How much revenue does MyoKardia generate?

What is MyoKardia's SIC code NAICS code?

How many employees does MyoKardia have currently?

What industry does MyoKardia belong to?

What technology does MyoKardia use?

What is MyoKardia's email format?

When was MyoKardia founded?

MyoKardia

Company Overview

Media & News

Bristol-Myers Squibb Co is developing ex vivo T-cell therapies using Prime's gene-editing reagents based on PASSIGE technology.

Bristol-Myers Squibb Co receives award Financing & Liquidity Award.

Bristol-Myers Squibb Co had issues with suit on Oct 4th '24.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?